Debra K. Liebert's most recent trade in Milestone Pharmaceuticals Inc was a trade of 16,793 Series A Common Warrants (right to buy) done . Disclosure was reported to the exchange on July 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 16,793 | 16,793 | - | - | Series A Common Warrants (right to buy) | |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 16,793 | 16,793 | - | - | Series B Common Warrants (right to buy) | |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 16,666 | 16,793 (0%) | 0% | - | Common Shares | |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 20 Oct 2022 | 10,000 | 10,000 (0%) | 0% | 5.3 | 52,900 | Common Shares |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Purchase of securities on an exchange or from another person at price $ 5.26 per share. | 20 Oct 2022 | 4,000 | 4,000 (0%) | 0% | 5.3 | 21,040 | Common Shares |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Other type of transaction at price $ 0.00 per share. | 14 Sep 2022 | 127 | 127 (0%) | 0% | 0 | Common Shares | |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Milestone Pharmaceuticals Inc | Debra K. Liebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |